Select Medical Holdings Co. (NYSE:SEM) Short Interest Update

Select Medical Holdings Co. (NYSE:SEM - Get Free Report) saw a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 4,470,000 shares, a growth of 17.3% from the February 13th total of 3,810,000 shares. Approximately 4.1% of the company's stock are short sold. Based on an average daily trading volume, of 1,040,000 shares, the short-interest ratio is presently 4.3 days.

Select Medical Stock Down 1.7 %

Shares of NYSE:SEM traded down $0.28 during trading on Friday, hitting $16.55. The company's stock had a trading volume of 2,448,652 shares, compared to its average volume of 757,452. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical has a fifty-two week low of $16.20 and a fifty-two week high of $40.98. The stock's 50-day moving average price is $18.59 and its two-hundred day moving average price is $25.62. The company has a market capitalization of $2.13 billion, a PE ratio of 10.03, a PEG ratio of 0.64 and a beta of 1.56.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. As a group, sell-side analysts expect that Select Medical will post 1.17 EPS for the current year.

Remove Ads

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd were paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.51%. The ex-dividend date was Monday, March 3rd. Select Medical's payout ratio is currently 15.15%.

Institutional Trading of Select Medical

Several institutional investors and hedge funds have recently bought and sold shares of SEM. Norges Bank acquired a new stake in Select Medical during the fourth quarter valued at approximately $29,556,000. The Manufacturers Life Insurance Company raised its position in shares of Select Medical by 2,552.7% during the 4th quarter. The Manufacturers Life Insurance Company now owns 1,596,414 shares of the health services provider's stock worth $30,092,000 after purchasing an additional 1,536,234 shares during the period. Hood River Capital Management LLC raised its position in shares of Select Medical by 404.8% during the 4th quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider's stock worth $33,096,000 after purchasing an additional 1,407,902 shares during the period. Point72 Asset Management L.P. raised its position in shares of Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider's stock worth $71,825,000 after purchasing an additional 1,216,263 shares during the period. Finally, Invesco Ltd. raised its position in shares of Select Medical by 48.6% during the 4th quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock worth $49,838,000 after purchasing an additional 864,852 shares during the period. Institutional investors and hedge funds own 89.48% of the company's stock.

Wall Street Analyst Weigh In

SEM has been the subject of several analyst reports. UBS Group decreased their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research report on Friday, January 3rd. Royal Bank of Canada decreased their target price on Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research report on Monday, February 24th. StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Finally, Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a research note on Monday, February 24th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $27.25.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.